| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/01/2004 | US20040127472 Use of anecortave acetate for the protection of visual acuity in patients with age related macular degeneration |
| 07/01/2004 | US20040127466 treatment and prevention of bone diseases in humans, including osteoporosis in postmenopausal women, Paget's Disease and hypercalcemia, by administration of a bisphosphonate in an inhalation form |
| 07/01/2004 | US20040127461 contact lens disinfecting solution; |
| 07/01/2004 | US20040127459 Sodium hyaluronate microspheres |
| 07/01/2004 | US20040127454 Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases |
| 07/01/2004 | US20040127425 Control of nitric oxide bioactivity by perfluorocarbons |
| 07/01/2004 | US20040127413 for treatment of malnourished subjects or those in hypercatabolism condition |
| 07/01/2004 | US20040127405 Methods for treating lung infections and lung tumors and for treating and preventing lung metastases |
| 07/01/2004 | US20040127397 covalently attaching the active agent to the N-terminus, the C-terminus or directly to the amino acid side chain of an oligopeptide or polypeptide such that endogeous intestinal peptidases will release said agent |
| 07/01/2004 | US20040127389 Effervescent solid composition of matter |
| 07/01/2004 | US20040126886 Liposome for incorporating large amounts of hydrophobic substances |
| 07/01/2004 | US20040126884 Transfecting heterologous gene sequences into mucosal cells, over a period of months, using naked DNA adhered to microparticles comprising a synthetic, biocompatible, biodegradable matrix |
| 07/01/2004 | US20040126497 drying takes place in a first drying stage at between 30 and 50 degrees C., in a second drying stage at between 35 and 80 degrees C., and in third drying stage at between 25 and 50 degrees C. |
| 07/01/2004 | US20040126448 Rapid composition with cocoa and vehicle for administering by mouthfor sexual dysfunction with sweeteners, emulsifiers, solubilizers and flavors |
| 07/01/2004 | US20040126444 Cactaceae-based formulation having the property of fixing fats and method for obtaining same |
| 07/01/2004 | US20040126436 Mixture of bicarbonate and enzyme for rermoval of ear wax from ear canal |
| 07/01/2004 | US20040126431 Method for preparing microspheres containing a water-soluble substance |
| 07/01/2004 | US20040126430 includes capsaicin; patches |
| 07/01/2004 | US20040126429 bactericides comprising potassium clavulanate and amoxycillin; bilayer time-release tablets |
| 07/01/2004 | US20040126428 comprises opiates; |
| 07/01/2004 | US20040126427 beads/capsules; for treatment of cardiovascular disorders |
| 07/01/2004 | US20040126426 comprises paclitaxel, cisplatin, and hyaluronic acids; bioresorption; radiotherapy; for treatment of cancer |
| 07/01/2004 | US20040126425 Systems, methods and apparatuses for manufacturing dosage forms |
| 07/01/2004 | US20040126424 comprises stiffening agents for ameliorating side effects associated with adminstration of lipase inhibitors (anal leakage of undigested fat or oil); for treatment of diabetes |
| 07/01/2004 | US20040126423 Pharmaceutical formulation |
| 07/01/2004 | US20040126422 cushioning beads/tablets/capsules with sustained release coating, formed via compression and lyophilization |
| 07/01/2004 | US20040126421 formed from peptide having ubiquitinatable region and antigenic region (with leukemia-/sarcoma- associated oncofusion protein breakpoint region), pH-sensitive liposomal carrier and bilayer-associated adjuvant; vaccines |
| 07/01/2004 | US20040126420 phosphatidylcholine, sphingomyelin, phosphatidyl ethanolamine, phosphatidyl serine, phosphatidyl inositol, and cholesterol; for removal of extra-/intra- vascular fibrin clots/adhesions; for use during surgery; for treatment of otitis |
| 07/01/2004 | US20040126419 Artificial tear formulation |
| 07/01/2004 | US20040126418 7-alpha-methyl-19-nortestosterone (MENT); androgens; improved bioavailability |
| 07/01/2004 | US20040126417 Transdermal buprenorphine to treat pain in sickle cell crisis |
| 07/01/2004 | US20040126416 Transdermal bupreorphine dosage regimen for analgesia |
| 07/01/2004 | US20040126415 such as (S)-6,8-dichloro-2-(trifluoromethyl)-2H-1-benzopyran-3-carboxylic acid; adhesive coated sheets |
| 07/01/2004 | US20040126412 Hemorrhoid treatment apparatus |
| 07/01/2004 | US20040126410 Method for preparing zinc-oligopeptide easily absorbable by the human body |
| 07/01/2004 | US20040126409 comprises cationic proteins/peptides; catheters/stents; contact lenses |
| 07/01/2004 | US20040126408 Bioerodible film for ophthalmic drug delivery |
| 07/01/2004 | US20040126403 Treatment for ectoparasites |
| 07/01/2004 | US20040126400 Delivery of therapeutic compounds via microparticles or microbubbles |
| 07/01/2004 | US20040126380 Administering a neurotoxin ; therapy for enlargement of prostate gland |
| 07/01/2004 | US20040126367 Oxidation resistance; storage at low temperature; overcoated with liposomes from soybean lecithin |
| 07/01/2004 | US20040126360 Oral formulations for proteins and polypeptides |
| 07/01/2004 | US20040126358 Interleukins; enteric coatings; inflammatory bowel disorders;Crohn' sdisease |
| 07/01/2004 | US20040126347 hydrofluoroether cosmetic compositions for, make-up, solar protection, perfume, hair removal cream, deodorants, anti-transpiration or shampoo products, and the formulation of pharmaceutical compositions to be applied to the skin |
| 07/01/2004 | US20040126343 a solution, for topical application to a nail of a patient, comprising DMSO a medicine, water and a moisturizing agent for assisting in the retention of moisture in the nail and preventing dehydrating, a dispersant and a solubilizing agent |
| 07/01/2004 | US20040126333 by means of a therapeutic agent delivery device placed within the periodontal pocket, such that release of the therapeutic agents occurs in the immediate vicinity of the disease process, so that biocompatibility or allergic problems cannot arise |
| 07/01/2004 | US20040126332 has suspended therein flakes of a water hydratable film comprised of a homogeneous mixture of a water soluble hydroxyalkyl cellulose polymer and starch, the film matrix having entrained therein a therapeutic, cosmetic or decorative agent |
| 07/01/2004 | US20040126330 Nicotine-containing film preparation |
| 07/01/2004 | US20040126329 Delivery of analgesics through an inhalation route |
| 07/01/2004 | US20040126328 Arerosol; heating drug, vaporization, cooling |
| 07/01/2004 | US20040126327 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route |
| 07/01/2004 | US20040126326 Delivery of antidepressants through an inhalation route |
| 07/01/2004 | US20040126325 Medicinal aerosol solution formulation products with improved chemical stability |
| 07/01/2004 | US20040126324 Mixture of ion exchange resin and drug |
| 07/01/2004 | US20040126323 Transdermal dosage form comprising an active agent and a salt and free-base form of an adverse agent |
| 07/01/2004 | US20040126322 Polymeric gas or air filled microballoons usable as suspensions in liquid carriers for ultrasonic echography |
| 07/01/2004 | US20040126321 Forming images; medical diagnosis; ultrasonic images enhancement; suspension of gas bubbles |
| 07/01/2004 | US20040124185 Pore structures for reduced pressure aerosolization |
| 07/01/2004 | US20040123775 Spraying composition |
| 07/01/2004 | DE202004007434U1 Film tablet, to carry high dosage medications, has a structured notch in one main surface to allow accurate parts to be broken off without a risk of over or under dosing |
| 07/01/2004 | DE202004006036U1 Base gel, for application as a body lotion to correct acid imbalance through a faulty metabolism, is formulated to be applied three times a week overnight without a need for treatment baths |
| 07/01/2004 | DE10351663A1 Stable, accurately dosable inhalable powder medicament for treating asthma or chronic obstructive pulmonary disease, containing tiotropium, specific form of salmeterol xinafoate and auxiliary |
| 07/01/2004 | DE10260921A1 Verfahren zum Überziehen von Substraten für pharmazeutische Anwendungen mit einem Gemisch aus zwei filmbildenden Überzugsmitteln A method for coating substrates for pharmaceutical applications with a mixture of two film-forming coating compositions |
| 07/01/2004 | DE10260920A1 Verfahren zur Herstellung von Arnzeiformen oder Nahrungsergänzungsmitteln mit pigmentierten Polymerüberzügen A process for preparing Arnzeiformen or food supplements with pigmented polymer coatings |
| 07/01/2004 | DE10260919A1 Verfahren zur Herstellung von überzogenen Arzneiformen und Nahrungsergänzungsmitteln mit Konzentrationsgradienten im Überzug Process for the preparation of coated dosage forms and supplements with concentration in the coating |
| 07/01/2004 | CA2810477A1 Oral drug delivery system |
| 07/01/2004 | CA2808592A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome |
| 07/01/2004 | CA2808584A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome |
| 07/01/2004 | CA2808190A1 A set of oligo-nucleotides against hiv infection and its application in the prevention and treatment of acquired immune deficiency syndrome |
| 07/01/2004 | CA2801155A1 Oral drug delivery system |
| 07/01/2004 | CA2779684A1 Immunization of fish with plant-expressed recombinant proteins |
| 07/01/2004 | CA2510261A1 Formulation comprising fenofibric acid, a physiologically acceptable salt or derivative thereof |
| 07/01/2004 | CA2510249A1 Complex coacervate encapsulate comprising lipophilic core |
| 07/01/2004 | CA2510223A1 Transdermal buprenorphine dosage regimen for analgesia |
| 07/01/2004 | CA2510043A1 Tiotropium containing hfc solution formulations |
| 07/01/2004 | CA2510038A1 Process for the chemical stabilization of a solubilized retinoid in a solvent using a base |
| 07/01/2004 | CA2509830A1 Pharmaceutical compositions of sertaconazole for vaginal use |
| 07/01/2004 | CA2509620A1 Light-shielding agent and film-forming composition |
| 07/01/2004 | CA2509216A1 Pharmaceutical porous particles |
| 07/01/2004 | CA2509101A1 A topical nanoparticulate spironolactone formulation |
| 07/01/2004 | CA2507522A1 Oral drug delivery system |
| 07/01/2004 | CA2506807A1 Controlled release preparations comprising tramadol and topiramate |
| 07/01/2004 | CA2503147A1 Stable topiramate formulations |
| 07/01/2004 | CA2498043A1 Preparation of submicron sized particles with polymorph control and new polymorph of itraconazole |
| 07/01/2004 | CA2494673A1 Platinum aggregates and process for producing the same |
| 06/30/2004 | EP1433525A1 Sensitive substance encapsulation |
| 06/30/2004 | EP1433485A2 A uro-genital condition treatment system |
| 06/30/2004 | EP1433482A1 Aqueous preparation containing a shark-derived chondroitin iron sulfate colloid |
| 06/30/2004 | EP1433478A1 Pharmaceutical formulae for thyroid hormones and procedures for obtaining them |
| 06/30/2004 | EP1433387A1 Solid granules containing carotenoids |
| 06/30/2004 | EP1432803A2 Fragments of the human zn-alpha2-glycoprotein and their use in methods of treatment of obesity |
| 06/30/2004 | EP1432738A1 Carbohydrate binding domain containing fusion proteins for delivery of therapeutic and other agents, and compositions containing them |
| 06/30/2004 | EP1432729A2 Peyers's patch and/or m-cell targeting ligands |
| 06/30/2004 | EP1432681A1 Pseudopolymorphic forms of carvedilol |
| 06/30/2004 | EP1432460A2 Bioactive materials for aneurysm repair |
| 06/30/2004 | EP1432459A1 Inhibition of exoprotein production using aromatic compositions |
| 06/30/2004 | EP1432457A1 Sanitary napkins with hydrophobic lotions |
| 06/30/2004 | EP1432449A1 Water-in-oil emulsions comprising vinyl polymers carrying acidic groups in side chains, compositions, and methods |
| 06/30/2004 | EP1432442A2 Vaccine |
| 06/30/2004 | EP1432440A2 Adjuvants for nucleic acid vaccines |